Gene-specific response to MuSK agonist antibody in the treatment of Congenital Myasthenic Syndromes

Kelly Ho(Children's Hospital of Eastern Ontario), Hanns Lochmüller(University of Ottawa)

bioRxiv (Cold Spring Harbor Laboratory)

August 30, 2025

10.1101/2025.08.29.673058

Cited by 0

Related Papers

Hexosamine Biosynthetic Pathway Mutations Cause Neuromuscular Transmission Defect

|The American Journal of Human Genetics|2011|172

A Deficiency in Glutamine-Fructose-6-Phosphate Transaminase 1 (Gfpt1) in Skeletal Muscle Results in Reduced Glycosylation of the Delta Subunit of the Nicotinic Acetylcholine Receptor (AChRδ)

|Biomolecules|2024|3

Development of a riboflavin-responsive model of riboflavin transporter deficiency in zebrafish

|Human Molecular Genetics|2024|1